<PAGE>
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
______________________________
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTIONS 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): July 31, 1998
FRESENIUS MEDICAL CARE HOLDINGS, INC.
-------------------------------------
(Exact name of registrant as specified in its charter)
New York
--------
(State or other jurisdiction of incorporation)
1-3720 13-3461988
------ ----------
(Commission File Number) (IRS Employer Identification No.)
Two Ledgemont Center, 95 Hayden Avenue Lexington, Massachusetts 02420
-------------------------------------------------------------------------
(Address or principal executive offices) (Zip Code)
Registrant's telephone number, including area codes: (781) 402-9000
Not Applicable
---------------------------------------------
(Former name or former address, if changed since last report)
<PAGE>
ITEM 7. FINANCIAL STATEMENTS AND EXHIBITS
Attached hereto as Exhibit 99 are quarterly statements of operations of
Fresenius Medical Care AG, the parent corporation of the Registrant, for 1996,
1997 and the first quarter of 1998 showing the results of operations for its
core and divested non-core businesses.
SIGNATURES
Pursuant to the requirements of the Securities Act of 1934, the Registrant
has duly caused this report to be signed on its behalf by the undersigned
thereunto duly authorized.
FRESENIUS MEDICAL CARE
HOLDINGS, INC.
/s/ Ben J. Lipps
------------------
DATE: July 30, 1998 Name: Ben J. Lipps
Title: Chief Executive Officer
2
<PAGE>
EXHIBIT 99
FRESENIUS MEDICAL CARE AG
RESTATEMENT OF HISTORICAL FINANCIAL DATA DUE TO
DIVESTITURE OF U.S. HOMECARE AND DIAGNOSTICS
<TABLE>
<CAPTION>
(IN MILLION US $ EXCEPT PER SHARE DATA)
1996 1997 1998
Q1 Q2 Q3 Q4 Full year Q1 Q2 Q3 Q4 Full year Q1
pro pro pro pro pro
forma forma forma forma forma
-------------------------------------- -------------------------------- ------
<S> <C> <C> <C> <C> <C> <C> <C> <C> <C> <C> <C> <C>
CONTINUING OPERATIONS
SALES
Dialysis Care 388 416 411 432 1,647 435 463 483 520 1,901 542
Dialysis Products 256 252 260 275 1,043 253 280 252 288 1,073 279
-------------------------------------- -------------------------------- ------
644 668 671 707 2,690 688 743 735 808 2,974 821
North America 455 483 486 501 1,925 501 526 545 584 2,156 607
International 189 185 185 206 765 167 217 190 224 818 214
-------------------------------------- -------------------------------- ------
644 668 671 707 2,690 688 743 735 808 2,974 821
EBITDA
North America 77 91 86 104 358 105 116 118 118 457 121
International 44 37 5O 47 178 49 54 45 44 192 53
Corporate -1 -2 -2 -2 -7 -1 -3 -2 -2 -8 -2
-------------------------------------- -------------------------------- ------
120 126 134 149 529 153 167 161 16O 641 172
Earnings before interest
and taxes 59 75 82 89 314 91 105 93 95 391 104
Earnings before income taxes 30 35 15 49 129 48 61 56 48 207 55
Net income from continuing operations 13 17 -1 19 48 22 30 27 25 104 29
- ----------------------------------------------------------------------------------------------------------------------------------
Net income (loss) from
Discontinued operations 5 2 -9 -2 -4 2 0 -6 -8 -14 -4
Net income (loss) 18 19 -10 17 44 24 30 19 17 90 25
- ----------------------------------------------------------------------------------------------------------------------------------
Earnings per share
Continuing operations 0.17 0.23 -0.02 0.25 0.64 0.30 0.40 0.34 0.30 1.34 0.35
Total operations 0.24 0.26 -0.14 0.22 0.58 0.32 0.40 0.24 0.20 1.16 0.30
</TABLE>
